G12.23 Primary lateral sclerosis

✓ Billable ICD-10-CM 2026
Open G12.23 in Web App →

The ICD-10-CM code for Primary lateral sclerosis is G12.23 (FY2026). It is a billable, claim-ready diagnosis code.

Classification

Section
G10-G14: Systemic atrophies primarily affecting the central nervous system (G10-G14)
Category G12
13 codes (11 billable)
FY2026 Status
Stable since FY2024

Also Known As

ICD-10-CM Alphabetic Index entries that lead to G12.23:

  • Paralysis, paralytic (complete) (incomplete) › lateral
  • Sclerosis, sclerotic › primary, lateral
  • Sclerosis, sclerotic › lateral (amyotrophic) (descending) (spinal) › primary
  • Sclerosis, sclerotic › spinal (cord) (progressive) › lateral (amyotrophic) › progressive

U.S. Hospital Utilization

  • An estimated 1,070 U.S. inpatient stays in 2023 included G12.23 among the documented diagnoses.
  • 150 stays listed it as the principal diagnosis.

Source: National Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, 2016–2023. National survey-weighted estimates.

Official Coding Guidelines

Dominant/nondominant side (TOC entry)

a. Dominant/nondominant side ................................................................................................. 45

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.6.a
Pain - Category G89 (TOC entry)

b. Pain - Category G89.............................................................................................................. 45

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.6.b

Source: CMS — ICD-10-CM Official Guidelines for Coding and Reporting, FY2026

References

Related Codes

Search all 70,000+ ICD-10-CM codes →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2025-10-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial